Beers, S. A., Cragg, M. S., & Glennie, M. J. (2008). Response: Superior B cell–depleting activity of type II anti-CD20 mAb is not due to activation of complement. American Society of Hematology.
Chicago-stil citatBeers, Stephen A., Mark S. Cragg, och Martin J. Glennie. Response: Superior B Cell–depleting Activity of Type II Anti-CD20 MAb Is Not Due to Activation of Complement. American Society of Hematology, 2008.
MLA-referensBeers, Stephen A., Mark S. Cragg, och Martin J. Glennie. Response: Superior B Cell–depleting Activity of Type II Anti-CD20 MAb Is Not Due to Activation of Complement. American Society of Hematology, 2008.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.